VONOPRAZAN- VERSUS PROTON-PUMP INHIBITOR-BASED THIRD-LINE 7-DAY SITAFLOXACIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A PROSPECTIVE, RANDOMIZED TRIAL

被引：0
|
作者：
Sue, Soichiro
Shibata, Wataru
Kaneko, Hiroaki
Irie, Kuniyasu
Sasaki, Tomohiko
Kondo, Masaaki
Maeda, Shin
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1302
引用
收藏
页码：S927 / S928
页数：2
相关论文
共 50 条
  • [31] Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea
    Kim, Y. S.
    Kim, S. J.
    Yoon, J. H.
    Suk, K. T.
    Kim, J. B.
    Kim, D. J.
    Kim, D. Y.
    Min, H. J.
    Park, S. H.
    Shin, W. G.
    Kim, K. H.
    Kim, H. Y.
    Baik, G. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) : 1098 - 1105
  • [32] Efficacy of 7-Day and 14-Day Moxifloxacin-Based Triple Therapy Versus 7-Day and 14-Day Bismuth-Containing Quadruple Therapy As Second-Line Treatment for Helicobacter pylori Infection
    Lee, Seong Tae
    Lee, Dong Ho
    Kim, Nayoung
    Park, Young Su
    Shin, Cheol Min
    Jo, Hyun Jin
    Lim, Ji Hyun
    GASTROENTEROLOGY, 2013, 144 (05) : S331 - S331
  • [33] A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea
    Lee, Jung Won
    Kim, Nayoung
    Kim, Jung Mogg
    Nam, Ryoung Hee
    Kim, Jae Yeon
    Lee, Ju Yup
    Lee, Dong Ho
    Jung, Hyun Chae
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 917 - 924
  • [34] Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication:: Neither treatment duration provides acceptable eradication rate in Korea
    Kim, Byeong Gwan
    Lee, Dong Ho
    Ye, Byong Duk
    Lee, Kwang Hyuck
    Kim, Beung Wook
    Kim, Sang Gyun
    Kim, Sang Woo
    Kim, Sung Kook
    Kim, Jae J.
    Kim, Hak Yang
    Park, Jong Jae
    Park, Chang Young
    Baik, Gwang Ho
    Lee, Yong Chan
    Lee, Jun Haeng
    Lee, Jin Hyug
    Chun, Hoon Jai
    Hahm, Ki Baik
    Hong, Su Jin
    Lee, Sang Woo
    Jung, Hyun Chae
    HELICOBACTER, 2007, 12 (01) : 31 - 35
  • [35] Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers
    Tulassay, Zsolt
    Stolte, Manfred
    Engstrand, Lars
    Butruk, Eugeniusz
    Malfertheiner, Peter
    Dite, Petr
    Tchernev, Konstantin
    Wong, Benjamin C. Y.
    Gottlow, Mattis
    Eklund, Stefan
    Wrangstadh, Michael
    Herszenyi, Laszlo
    Nagy, Peter
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) : 1048 - 1058
  • [36] Comparison of metronidazole versus clarithromycin in first-line vonoprazan-based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan
    Sue, Soichiro
    Oka, Hiroyuki
    Kunishi, Yosuke
    Suzuki, Yuichi
    Suzuki, Shingo
    Kaneko, Takashi
    Komatsu, Kazuo
    Naito, Makoto
    Kato, Yoshio
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    JGH OPEN, 2024, 8 (04):
  • [37] Efficacy of 7-day high dose esomeprazole-based triple therapy versus 7-day standard dose non-esomeprazole-based triple therapy for first-line treatment of Helicobacter pylori infection
    Heo, Jae Joon
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Song, Jiyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 91 - 91
  • [38] Efficacy of 7-day high dose esomeprazole-based triple therapy versus 7-day standard dose non-esomeprazole-based triple therapy for first-line treatment of Helicobacter pylori infection
    Lee, Y.
    Kim, S.
    Park, M.
    Park, S.
    Moon, W.
    Kim, J.
    Jung, K.
    Song, J.
    HELICOBACTER, 2017, 22
  • [39] Eradication of Helicobacter pylori with 10-Day Sitafloxacin-based Triple Therapy as a Third- or Fourth-Line Rescue Therapy: Preliminary Results of Open-Label Randomized Trial
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Fukuhara, Seiichiro
    Okada, Sawako
    Hirata, Kenro
    Tsugawa, Hitoshi
    Hibi, Toshifumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S56 - S57
  • [40] Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
    Lee, Hyuk
    Kim, Beom Jin
    Kim, Sang Gyun
    Kim, Jin Il
    Choi, Il Ju
    Lee, Yong Chan
    Kim, Jae G.
    Kim, Jae J.
    TRIALS, 2017, 18
12345